Trump inks deal with 9 pharmaceutical companies to lower drug costs
Summary
President Donald Trump announced that his administration has made deals with nine more drug companies to help reduce prescription drug costs for Americans. These agreements add to previous ones, involving most of the pharmaceutical market, and are expected to save consumers over $600 billion soon.Key Facts
- President Trump’s administration signed agreements with nine additional pharmaceutical companies.
- These deals aim to lower the prices people pay for prescription drugs.
- The total saved by these agreements is projected to be more than $600 billion in a short time.
- The nine companies include Alcon, Astellas Pharma, BeOne Medicines, BridgeBio, CSL, Kyowa Kirin, Sun Pharma, Teva Pharmaceuticals, and UCB.
- Together with earlier deals, 26 companies now represent 90% of the U.S. pharmaceutical market.
- The companies will provide their drugs to all state Medicaid programs, offering more savings to Americans.
- The companies agreed to invest $19.6 billion in drug manufacturing.
- Earlier efforts include the TrumpRx website, which offers drug discounts to consumers.
Read the Full Article
This is a fact-based summary from The Actual News. Click below to read the complete story directly from the original source.
